CAAS Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-600
Closed -$340K 360
2020
Q2
$340K Buy
+600
New +$340K 0.01% 155